Next Article in Journal
The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
Next Article in Special Issue
Screening for the Key Proteins Associated with Rete Testis Invasion in Clinical Stage I Seminoma via Label-Free Quantitative Mass Spectrometry
Previous Article in Journal
Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4+ and CD8+ T Cell Responses in the Etiologic Pathway to Endemic Burkitt Lymphoma
Previous Article in Special Issue
Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes
 
 
Communication

Article Versions Notes

Cancers 2021, 13(21), 5377; https://doi.org/10.3390/cancers13215377
Action Date Notes Link
article xml file uploaded 27 October 2021 10:21 CEST Original file -
article xml uploaded. 27 October 2021 10:21 CEST Update https://www.mdpi.com/2072-6694/13/21/5377/xml
article pdf uploaded. 27 October 2021 10:21 CEST Version of Record https://www.mdpi.com/2072-6694/13/21/5377/pdf
article html file updated 27 October 2021 10:22 CEST Original file -
article html file updated 30 July 2022 13:16 CEST Update https://www.mdpi.com/2072-6694/13/21/5377/html
Back to TopTop